Market Research: Cervical Cancer Market is Forecast to Show Slow Growth
(firmenpresse) - ROCKVILLE, MD -- (Marketwire) -- 01/11/12 -- MarketResearch.com has announced the addition of the new report "Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their collection of Pharmaceuticals market reports. For more information, visit
The report estimates that the global cervical cancer market was worth $1,793.3m in 2010, after increasing at a Compound Annual Growth Rate (CAGR) of 62.7% during 2006-2010. During 2010-2018, the market is expected to record a CAGR of 3.6%, from $1,793.3m in 2010 to $2,377.3m in 2018.
The overall cervical cancer market consists of the cervical cancer prophylactics market and the cervical cancer therapeutics market. The cervical cancer prophylactics market grew at a CAGR of 61.5% from $234.8m in 2006 to $1,598.7m in 2010. The cervical cancer therapeutics market grew at a CAGR of 4.3% from $157.3m in 2005 to $194.5m in 2010.
The prophylactics market experienced significant growth in the historic period due to the launch of Gardasil (Human Papillomavirus (HPV) quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant) and Cervarix (HPV bivalent (types 16 and 18) vaccine, recombinant). Gardasil was approved in the US and Europe in 2006 and in Japan in 2011. Similarly, Cervarix was approved in Europe in 2007 and in the US and Japan in 2009. The prophylactics market is expected to grow in the forecast period to 2018 due to the expected launch of the First-In-Class (FIC) vaccine, V503 in 2013, although growth will be slow.
Growth in the cervical cancer therapeutics market is expected to decline in the forecast period until 2018, primarily due to the generic erosion of Hycamtin, the only approved therapeutic treatment option available in the market for advanced and recurrent cervical cancer patients. Its patent expired in the US in 2010 and will expire in Europe in 2011. In Japan, the therapeutics market is expected to show steady growth during the forecast period, attributed to the expected launch of two upcoming FIC molecules.
For more information, visit
MarketResearch.com is the leading provider of global market intelligence products and services. With over 300,000 research reports from more than 700 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. For more information, call Veronica Franco at 240-747-3016 or visit .
Contact:
Veronica Franco
MarketResearch.com
240.747.3016
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.01.2012 - 10:08 Uhr
Sprache: Deutsch
News-ID 102982
Anzahl Zeichen: 0
contact information:
Town:
ROCKVILLE, MD
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 240 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Market Research: Cervical Cancer Market is Forecast to Show Slow Growth"
steht unter der journalistisch-redaktionellen Verantwortung von
MarketResearch.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
